Authors: Muhammad Adil, Qamar Ul Hassan, Adeeba Naseer, Muhammad Shazad Shafiq, Sehrish Gul, Asad Ullah, Farrah Deeba, Ghulam Murtaza, Muhammad Azam Farooq Kasli and Arsalan Said
DOI: http://dx.doi.org/10.71081/cvj/2023.020
Abstract
Antimicrobial resistance (AMR) records a resounding global health alarm,
posturing ample challenges to the effectual treatment of bacterial infections.
As the predominance of drug-resistant bacteria continues to rise, the
improvement and implementation of advanced techniques for AMR
detection have become essential. This review offers a broad overview of the
up-to-date methodologies employed in the identification and classification
of antimicrobial resistance in bacteria. In recent years, genomic approaches
have revolutionized AMR detection, allowing for rapid and accurate
evaluation of resistance genes and mutations. Whole genome sequencing,
coupled with bioinformatics tools, has enabled the chasing of resistance
evolution and transmission dynamics. Additionally, transcriptomics and
proteomics have explained the underlying mechanisms of AMR, assisting in
the development of targeted therapies. Furthermore, advanced phenotypic
assays, such as microfluidic systems and mass spectrometry-based
techniques, have improved our skill in assessing bacterial susceptibility to
antibiotics. The addition of artificial intelligence and machine learning
algorithms has simplified data analysis and expectation of resistance
profiles with high precision. This review highlights the benefits and
restraints of each technique and reflects their potential for clinical and
public health applications. The continuing challenges in AMR detection,
including the emergence of novel resistance mechanisms and the need for
regulation, are also addressed. The review concludes that more accurate,
precise, and economical methods are needed to understand the exact
situation of resistance to adjust the management strategies accordingly.
Keywords: AMR; resistance; Bacteria; Sensitivity; Antimicrobials